LEXARIA BIOSCIENCE CORP. Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest
LEXARIA BIOSCIENCE CORP. (LEXX) reported Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest of -$10.92 thousand for the 3-month period ending 2021-02-28, per its 10-Q filed 2021-04-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossTaxPortionAttributableToNoncontrollingInterest · last filed 2021-04-14
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for the quarter ending 2021-02-28 was -$10.92K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for the quarter ending 2020-11-30 was -$14.09K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for the quarter ending 2020-08-31 was -$56.75K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for the quarter ending 2020-05-31 was -$29.27K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2020 was -$150.62K.
- LEXARIA BIOSCIENCE CORP. other comprehensive income (loss), tax, portion attributable to noncontrolling interest for fiscal 2019 was -$58.99K.
| Period end | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 3 month as first filed | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 12 month | Other Comprehensive Income (Loss), Tax, Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-02-28 | -$10.92K 10-Q · filed 2021-04-14 | -$25.01K derived: sum of 2 quarters · filed 2021-04-14 | -$81.76K derived: sum of 3 quarters · filed 2021-04-14 | -$111.03K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2020-11-30 | -$14.09K 10-Q · filed 2021-04-14 | -$70.84K derived: sum of 2 quarters · filed 2021-04-14 | -$100.11K derived: sum of 3 quarters · filed 2021-04-14 | -$147.26K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2020-08-31 | -$56.75K 10-Q · filed 2021-04-14 | -$86.02K derived: sum of 2 quarters · filed 2021-04-14 | -$133.17K derived: sum of 3 quarters · filed 2021-04-14 | -$150.62K 10-K · filed 2020-10-15 | ||
| 2020-05-31 | -$29.27K 10-Q · filed 2021-04-14 | -$76.42K derived: sum of 2 quarters · filed 2021-04-14 | -$93.87K derived: sum of 3 quarters · filed 2021-04-14 | -$131.60K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2020-02-29 | -$47.15K 10-Q · filed 2021-04-14 | -$64.60K derived: sum of 2 quarters · filed 2021-04-14 | -$102.33K derived: sum of 3 quarters · filed 2021-04-14 | -$118.46K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2019-11-30 | -$17.45K 10-Q · filed 2021-04-14 | -$55.18K derived: sum of 2 quarters · filed 2021-04-14 | -$71.31K derived: sum of 3 quarters · filed 2021-04-14 | $928.69K derived: sum of 4 quarters · filed 2021-04-14 | ||
| 2019-08-31 | -$37.73K derived: 10-K 12 month − 10-Q 9 month · filed 2020-10-15 | -$53.86K derived: sum of 2 quarters · filed 2020-10-15 | $946.14K derived: sum of 3 quarters · filed 2020-10-15 | -$58.99K 10-K · filed 2020-10-15 | ||
| 2019-05-31 | -$16.13K 10-Q · filed 2019-07-08 | $983.87K derived: sum of 2 quarters · filed 2020-06-29 | -$21.27K 10-Q · filed 2019-07-08 | |||
| 2019-02-28 | $1.00M 10-Q · filed 2020-06-29 | -$5.13K 10-Q · filed 2019-04-15 | -$5.13K 10-Q · filed 2019-04-15 | |||
| 2018-08-31 | -$70.00K 10-Q · filed 2020-01-09 | -$10.34K 10-K · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |